Utility of WHOQOL-BREF in measuring quality of life in Sickle Cell Disease

Monika Asnani1, Garth Lipps2, Marvin Reid1
1Sickle Cell Unit, Tropical Medicine Research Institute, University of the West Indies, Mona Campus, Kingston 7, Jamaica
2Department of Psychology, Sociology and Social Work, University of the West Indies, Mona Campus, Kingston 7, Jamaica

Tóm tắt

Từ khóa


Tài liệu tham khảo

Serjeant GR, Serjeant BE: Sickle Cell Disease. Third edition. Oxford: Oxford University Press; 2001.

McCaw-Binns A, Alexander SF, Lindo JL, Escoffery C, Spence K, Lewis-Bell K, Lewis G: Epidemiologic transition in maternal mortality and morbidity: new challenges for Jamaica. Int J Gynaecol Obstet 2007,96(3):226–232. 10.1016/j.ijgo.2006.12.002

Barton EN, Sargeant LA, Samuels D, Smith R, James J, Wilson R, Smith F, Falconer H, Yeates C, Smikle MF, et al.: A survey of chronic renal failure in Jamaica. West Indian Med J 2004,53(2):81–84.

Escoffery CT, Shirley SE: Causes of sudden natural death in Jamaica: a medicolegal (coroner's) autopsy study from the University Hospital of the West Indies. Forensic Sci Int 2002,129(2):116–121. 10.1016/S0379-0738(02)00268-2

Wierenga KJ, Hambleton IR, Lewis NA: Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study. Lancet 2001,357(9257):680–683. 10.1016/S0140-6736(00)04132-5

Wison Schaeffer JJ, Gil KM, Burchinal M, Kramer KD, Nash KB, Orringer E, Strayhorn D: Depression, disease severity, and sickle cell disease. J Behav Med 1999,22(2):115–126. 10.1023/A:1018755831101

Ohaeri JU, Shokunbi WA, Akinlade KS, Dare LO: The psychosocial problems of sickle cell disease sufferers and their methods of coping. Soc Sci Med 1995,40(7):955–960. 10.1016/0277-9536(94)00154-L

Jacob E: The pain experience of patients with sickle cell anemia. Pain Manag Nurs 2001,2(3):74–83. 10.1053/jpmn.2001.26119

Anie KA, Steptoe A, Bevan DH: Sickle cell disease: Pain, coping and quality of life in a study of adults in the UK. Br J Health Psychol 2002,7(Part 3):331–344. 10.1348/135910702760213715

Anie KA, Steptoe A: Pain, mood and opioid medication use in sickle cell disease. Hematol J 2003,4(1):71–73. 10.1038/sj.thj.6200227

Bodhise PB, Dejoie M, Brandon Z, Simpkins S, Ballas SK: Non-pharmacologic Management of Sickle Cell Pain. Hematology 2004,9(3):235–237. 10.1080/10245330410001701495

Strickland OL, Jackson G, Gilead M, McGuire DB, Quarles S: Use of focus groups for pain and quality of life assessment in adults with sickle cell disease. J Natl Black Nurses Assoc 2001,12(2):36–43.

Kater AP, Heijboer H, Peters M, Vogels T, Prins MH, Heymans HS: [Quality of life in children with sickle cell disease in Amsterdam area]. Ned Tijdschr Geneeskd 1999,143(41):2049–2053.

Thomas VJ, Taylor LM: The psychosocial experience of people with sickle cell disease and its impact on quality of life: Qualitative findings from focus groups. Br J Health Psychol 2002,7(Part 3):345–363. 10.1348/135910702760213724

Anie KA: Psychological complications in sickle cell disease. Br J Haematol 2005,129(6):723–729. 10.1111/j.1365-2141.2005.05500.x

Maxwell K, Streetly A, Bevan D: Experiences of hospital care and treatment seeking for pain from sickle cell disease: qualitative study. Bmj 1999,318(7198):1585–1590.

Midence K, Fuggle P, Davies SC: Psychosocial aspects of sickle cell disease (SCD) in childhood and adolescence: a review. Br J Clin Psychol 1993,32(Pt 3):271–280.

Asnani M: The Prevalence of Depression in Sickle Cell Disease in the Jamaican Cohort. Kingston, Jamaica.: University of the West Indies; 2004.

Brown RT, Kaslow NJ, Doepke K, Buchanan I, Eckman J, Baldwin K, Goonan B: Psychosocial and family functioning in children with sickle cell syndrome and their mothers. J Am Acad Child Adolesc Psychiatry 1993,32(3):545–553.

Gil KM, Abrams MR, Phillips G, Keefe FJ: Sickle cell disease pain: relation of coping strategies to adjustment. J Consult Clin Psychol 1989,57(6):725–731. 10.1037/0022-006X.57.6.725

Hasan SP, Hashmi S, Alhassen M, Lawson W, Castro O: Depression in sickle cell disease. J Natl Med Assoc 2003,95(7):533–537.

Thomas VJ, Hambleton I, Serjeant G: Psychological distress and coping in sickle cell disease: comparison of British and Jamaican attitudes. Ethn Health 2001,6(2):129–136. 10.1080/13557850120068450

McClish DK, Penberthy LT, Bovbjerg VE, Roberts JD, Aisiku IP, Levenson JL, Roseff SD, Smith WR: Health related quality of life in sickle cell patients: The PiSCES project. Health Qual Life Outcomes 2005,3(1):50. 10.1186/1477-7525-3-50

Asnani M, Lipps G, Reid M: Validation of the SF-36 in Jamaicans with Sickle Cell Disease. Psychology, Health & Medicine (accepted for publication April 2009)

WHOQOL Group: The World Health Organization Quality of Life Assessment: development and general psychometric properties. Soc Sci Med 1998,46(12):1569–1585. 10.1016/S0277-9536(98)00009-4

WHOQOL Group: Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 1998,28(3):551–558. 10.1017/S0033291798006667

Liang WM, Chen JJ, Chang CH, Chen HW, Chen SL, Hang LW, Wang JD: An empirical comparison of the WHOQOL-BREF and the SGRQ among patients with COPD. Qual Life Res 2008,17(5):793–800. 10.1007/s11136-008-9326-5

Skevington SM: Advancing cross-cultural research on quality of life: observations drawn from the WHOQOL development. World Health Organisation Quality of Life Assessment. Qual Life Res 2002,11(2):135–144. 10.1023/A:1015013312456

Sherlock P, Bennete H: The story of the Jamaican people. Kingston, Jamaica: Ian Randle Publishers; 2000.

Burckhardt CS, Anderson KL: The Quality of Life Scale (QOLS): Reliability, Validity, and Utilization. Health Qual Life Outcomes 2003,1(1):60. 10.1186/1477-7525-1-60

United Nations Development Programme: Human Development Report, Jamaica. 2008. [ http://www.jm.undp.org/files/Jamaica2ndNHDR.pdf ]

Skevington SM, Lotfy M, O'Connell KA: The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res 2004,13(2):299–310. 10.1023/B:QURE.0000018486.91360.00

Asnani M, Lipps G, Reid M: Component structure of the SF-36 in Jamaicans with Sickle Cell Disease. West Indian Medical Journal 2007,56(6):491–497.

Flanagan JC: Measurement of quality of life: current state of the art. Arch Phys Med Rehabil 1982,63(2):56–59.

StataCorp: Stata 8.2. 4905 Lakeway Drive, College Station, Texas 77845 USA; 1984.

WHOQOL Group: Introduction, administration, scoring and generic version of the assessment- field trial version. 1996.

Bland JM, Altman DG: Cronbach's alpha. Bmj 1997,314(7080):572.

Smith WR, Bovbjerg VE, Penberthy LT, McClish DK, Levenson JL, Roberts JD, Gil K, Roseff SD, Aisiku IP: Understanding pain and improving management of sickle cell disease: the PiSCES study. J Natl Med Assoc 2005,97(2):183–193.

Smith WR, Penberthy LT, Bovbjerg VE, McClish DK, Roberts JD, Dahman B, Aisiku IP, Levenson JL, Roseff SD: Daily assessment of pain in adults with sickle cell disease. Ann Intern Med 2008,148(2):94–101.

Stuart MJ, Nagel RL: Sickle-cell disease. Lancet 2004,364(9442):1343–1360. 10.1016/S0140-6736(04)17192-4

Unalan D, Soyuer F, Ozturk A, Mistik S: Comparison of SF-36 and WHOQOL-100 in patients with stroke. Neurol India 2008,56(4):426–432. 10.4103/0028-3886.44573

Baum KF, Dunn DT, Maude GH, Serjeant GR: The painful crisis of homozygous sickle cell disease. A study of the risk factors. Arch Intern Med 1987,147(7):1231–1234. 10.1001/archinte.147.7.1231

Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J: Guidelines for the management of the acute painful crisis in sickle cell disease. Br J Haematol 2003,120(5):744–752. 10.1046/j.1365-2141.2003.04193.x

Serjeant GR: The dilemma of defining clinical severity in homozygous sickle cell disease. Curr Hematol Rep 2004,3(5):307–309.

Solomon LR: Treatment and prevention of pain due to vaso-occlusive crises in adults with sickle cell disease: an educational void. Blood 2008,111(3):997–1003. 10.1182/blood-2007-07-089144

Skevington SM: Investigating the relationship between pain and discomfort and quality of life, using the WHOQOL. Pain 1998,76(3):395–406. 10.1016/S0304-3959(98)00072-4

Kato GJ, McGowan V, Machado RF, Little JA, Taylor Jt, Morris CR, Nichols JS, Wang X, Poljakovic M, Morris SM Jr, et al.: Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 2006,107(6):2279–2285. 10.1182/blood-2005-06-2373

Steinberg MH: Predicting clinical severity in sickle cell anaemia. Br J Haematol 2005,129(4):465–481. 10.1111/j.1365-2141.2005.05411.x

Cumming V, King L, Fraser R, Serjeant G, Reid M: Venous incompetence, poverty and lactate dehydrogenase in Jamaica are important predictors of leg ulceration in sickle cell anaemia. Br J Haematol 2008,142(1):119–125. 10.1111/j.1365-2141.2008.07115.x